Signaling: Enzymatic insights into an inherited genetic disorder

Mutations in an enzyme involved in protein degradation affect a signaling pathway that stimulates the development of the digestive tract.
  1. Liping Zhang
  2. Kelly G Ten Hagen  Is a corresponding author
  1. National Institutes of Health, United States

DNA sequencing has been very successful in identifying mutations associated with human genetic disorders, but understanding how the disruption of particular genes results in disease remains a constant challenge. One such example of this is the identification of mutations in a gene known as NGLY1 in patients with an inherited disorder (Need et al., 2012). NGLY1 encodes an enzyme that is found in the cytoplasm of all cells and is responsible for removing sugar chains known as N-glycans from proteins that are destined to be degraded (Figure 1A; Suzuki et al., 1993; Suzuki et al., 2016). Patients harboring mutations in this gene present with a multitude of symptoms, including delayed development, peripheral nerve disorders and low muscle tone (Enns et al., 2014; Caglayan et al., 2015; Lam et al., 2017). However, it is not clear how the loss of this enzyme leads to these symptoms.

The role of NGLY1 in protein processing and development.

(A) In humans and other animals the NGLY1 enzyme removes sugar chains called N-glycans (shown in green and blue) from proteins (purple) that are destined to be degraded via a process known as endoplasmic reticulum-associated degradation (ERAD). If NGLY1 removes a sugar chain from the amino acid asparagine (N), the latter becomes a different amino acid, aspartic acid (D), which may alter the activity of the protein. (B) The equivalent of the NGLY1 enzyme in the fruit fly is known as Pngl. In fruit flies, BMP signaling stimulates the development of the digestive system (left). Homodimers of a BMP ligand called Dpp (red) in a layer of tissue known as the visceral mesoderm (upper layer) activate BMP signaling, which then signals to cells in the endoderm (lower layer). Dpp fails to properly form homodimers in fruit flies with mutations in the Pngl gene, which disrupts BMP signaling within both the visceral mesoderm and the endoderm (right). Cells with active BMP signaling are shown in blue. GlcNAc, N-acetylglucosamine.

Now, in eLife, Hamad Jafar-Nejad and colleagues at Baylor College of Medicine and the RIKEN Global Research Cluster – including Antonio Galeone as first author – report new insights into the role of this enzyme in the development of the fruit fly, Drosophila melanogaster (Galeone et al., 2017). Fruit flies have served as excellent models for studying many aspects of human development and disease over the years. Taking advantage of sophisticated genetic tools unique to the fly, Galeone et al. show that the loss of a gene called Pngl – which is the fruit fly equivalent of NGLY1 – causes portions of the digestive tract to be malformed. Further experiments trace these defects back to when the digestive tract begins to form in the embryo and reveal that a signaling pathway known as bone morphogenetic protein (or BMP) signaling is disrupted in cells that will give rise to portions of the digestive tract.

The BMP pathway is of particular interest because it regulates many aspects of development in both fruit flies and mammals (Wang et al., 2014). Cells secrete molecules known as BMP ligands that then bind to specific receptors on the surface of cells to stimulate BMP signaling cascades (O'Connor et al., 2006). BMP ligands exist as dimers containing either two identical ligand molecules (homodimers) or two different ones (heterodimers). Galeone et al. demonstrate that a BMP ligand called Dpp forms fewer homodimers in the developing gut of flies with mutations in Pngl. This leads to defects in BMP signaling in two layers of tissue that are required for the digestive system to form properly (Figure 1B).

This study is the first to identify a specific signaling pathway that is disrupted in the absence of the Pngl enzyme and may provide insight into the underlying causes of some of the symptoms typically seen in patients with mutations in the NGLY1 gene. Whether patients have similar alterations in BMP signaling within specific cells or tissues remains to be determined, but this study will help to inform future investigations.

The findings of Galeone et al. raise a number of questions regarding how this enzyme works. An enzymatically inactive version of Pngl did not rescue specific digestive system defects, suggesting that Pngl activity is important for BMP signaling. However, it is not known whether the enzyme acts directly on Dpp to affect its ability to form homodimers. It is also possible that the loss of Pngl could affect BMP signaling indirectly, by influencing how other proteins within these cells are modified or degraded. BMP signaling within the affected cells may be uniquely sensitive to disruptions in the normal systems that regulate proteins at this stage of development. Additionally, not all phenotypes within the Pngl mutants are due to defects in BMP signaling, suggesting that the Pngl enzyme also affects other proteins and pathways. Direct examination of the N-glycans attached to Dpp and other proteins in wild type and Pngl-deficient tissues will begin to address some of these questions.

Finally, studies on the role of NGLY1 in other organisms suggest that this enzyme may have roles beyond the removal of N-glycans on proteins destined for degradation (Dalet et al., 2011; Figure 1A). There is also evidence suggesting NGLY1 has a role in cells that is independent of its enzymatic activity (Maerz et al., 2010). Regardless, the study by Galeone et al. demonstrates that loss of Pngl results in tissue- and stage-specific alterations in the BMP signaling pathway and provides a new lens through which we can begin to dissect how it influences other systems.

References

Article and author information

Author details

  1. Liping Zhang

    Liping Zhang is at the National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8637-4975
  2. Kelly G Ten Hagen

    Kelly G Ten Hagen is at the National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, United States

    For correspondence
    tenhagen@nidcr.nih.gov
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2057-8120

Publication history

  1. Version of Record published: September 14, 2017 (version 1)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 929
    Page views
  • 103
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Liping Zhang
  2. Kelly G Ten Hagen
(2017)
Signaling: Enzymatic insights into an inherited genetic disorder
eLife 6:e31127.
https://doi.org/10.7554/eLife.31127
  1. Further reading

Further reading

    1. Developmental Biology
    Erica J Hutchins, Shashank Gandhi ... Marianne E Bronner
    Short Report

    While neural crest development is known to be transcriptionally controlled via sequential activation of gene regulatory networks (GRNs), recent evidence increasingly implicates a role for post-transcriptional regulation in modulating the output of these regulatory circuits. Using available single-cell RNA-sequencing datasets from avian embryos to identify potential post-transcriptional regulators, we found that Elavl1, which encodes for an RNA-binding protein with roles in transcript stability, was enriched in the premigratory cranial neural crest. Perturbation of Elavl1 resulted in premature neural crest delamination from the neural tube as well as significant reduction in transcripts associated with the neural crest specification GRN, phenotypes that are also observed with downregulation of the canonical Wnt inhibitor Draxin. That Draxin is the primary target for stabilization by Elavl1 during cranial neural crest specification was shown by RNA-sequencing, RNA immunoprecipitation, RNA decay measurement, and proximity ligation assays, further supporting the idea that the downregulation of neural crest specifier expression upon Elavl1 knockdown was largely due to loss of Draxin. Importantly, exogenous Draxin rescued cranial neural crest specification defects observed with Elavl1 knockdown. Thus, Elavl1 plays a critical a role in the maintenance of cranial neural crest specification via Draxin mRNA stabilization. Together, these data highlight an important intersection of post-transcriptional regulation with modulation of the neural crest specification GRN.

    1. Developmental Biology
    2. Neuroscience
    Jennifer M Lin, Tyler A Mitchell ... Paolo Emanuele Forni
    Research Article Updated

    Neuronal identity dictates the position in an epithelium, and the ability to detect, process, and transmit specific signals to specified targets. Transcription factors (TFs) determine cellular identity via direct modulation of genetic transcription and recruiting chromatin modifiers. However, our understanding of the mechanisms that define neuronal identity and their magnitude remain a critical barrier to elucidate the etiology of congenital and neurodegenerative disorders. The rodent vomeronasal organ provides a unique system to examine in detail the molecular mechanisms underlying the differentiation and maturation of chemosensory neurons. Here, we demonstrated that the identity of postmitotic/maturing vomeronasal sensory neurons (VSNs), and vomeronasal-dependent behaviors can be reprogrammed through the rescue of Tfap2e/AP-2ε expression in the Tfap2eNull mice, and partially reprogrammed by inducing ectopic Tfap2e expression in mature apical VSNs. We suggest that the TF Tfap2e can reprogram VSNs bypassing cellular plasticity restrictions, and that it directly controls the expression of batteries of vomeronasal genes.